Literature DB >> 2542607

Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

M T Chin1, T R Broker, L T Chow.   

Abstract

The human papillomavirus type 11 enhancer, when linked to the minimal simian virus 40 early promoter, has been dissected into two domains in monkey kidney CV-1 cells, one being constitutive (designated CEI) and the other inducible by trans-acting E2 proteins encoded by homologous and heterologous papillomaviruses (H. Hirochika, T.R. Broker, and L.T. Chow, J. Virol. 61:2599-2606, 1987; H. Hirochika, R. Hirochika, T.R. Broker, and L.T. Chow, Genes Dev. 2:54-67, 1988). We have demonstrated that the natural promoter regulated by this enhancer is located immediately upstream of the E6 open reading frame (the E6 promoter). We have mapped the cap site to nucleotide 99 by RNase protection. We further demonstrate a second constitutive enhancer element, CEII, which is required for transcription from the E6 promoter in the human cervical carcinoma cell lines C-33A and HeLa but not in CV-1 cells. By deletion mapping, we have localized this cell type-specific domain to 71 base pairs by using chloramphenicol acetyltransferase assays. Deletion of either CEI or CEII dramatically decreased the constitutive activity of the enhancer and the E6 promoter, whereas multimerization of either domain in the absence of the other could independently restore expression. Furthermore, when either of these elements was deleted, the full-length E2 protein of human papillomavirus type 11 abolished the remaining basal E6 promoter activity, demonstrating for the first time that the enhancer-activating E2 protein of human papillomaviruses can also function as a transcriptional repressor for the homologous E6 viral promoter. The presence of multiple copies of each element in tandem overcomes the repression by the E2 protein. The effects of CEII are at the level of transcription, without changing the cap site. By gel shift assay, we have shown that a protein present in nuclear extracts of C-33A and HeLa cervical carcinoma cells binds to the newly identified constitutive element II. This protein did not bind the simian virus 40 enhancer, nor did it bind to the enhancer region of many other papillomaviruses tested. UV cross-linking experiments revealed major 44-kilodalton and minor 34-kilodalton proteins that bound specifically to CEII. These two proteins are either related or bind to CEII with high cooperativity. We conclude that transcriptional activities directed by the enhancer and E6 promoter reflect an intricate balance among viral and cellular factors. We present a model on the regulation of the E6 promoter by host and viral transcription factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542607      PMCID: PMC250851     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Effect of non-contacted bases on the affinity of 434 operator for 434 repressor and Cro.

Authors:  G B Koudelka; S C Harrison; M Ptashne
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

2.  Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.

Authors:  W C Phelps; P M Howley
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements.

Authors:  R F Rando; W D Lancaster; P Han; C Lopez
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

4.  A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.

Authors:  K A Jones; J T Kadonaga; P J Rosenfeld; T J Kelly; R Tjian
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

5.  The pseudorabies immediate early protein stimulates in vitro transcription by facilitating TFIID: promoter interactions.

Authors:  S M Abmayr; J L Workman; R G Roeder
Journal:  Genes Dev       Date:  1988-05       Impact factor: 11.361

6.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

7.  Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter.

Authors:  T Kanda; S Watanabe; K Yoshiike
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

8.  Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.

Authors:  K Seedorf; T Oltersdorf; G Krämmer; W Röwekamp
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

9.  Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.

Authors:  T H Haugen; T P Cripe; G D Ginder; M Karin; L P Turek
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

10.  Differentially expressed bovine cytokeratin genes. Analysis of gene linkage and evolutionary conservation of 5'-upstream sequences.

Authors:  M Blessing; H Zentgraf; J L Jorcano
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  35 in total

1.  A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

Authors:  G L Bream; P Vaillancourt; M R Botchan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Transcription factor AP2 and its role in epidermal-specific gene expression.

Authors:  A Leask; C Byrne; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice.

Authors:  C Byrne; E Fuchs
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region.

Authors:  S Pattison; D G Skalnik; A Roman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor.

Authors:  S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.

Authors:  F Thierry; N Dostatni; F Arnos; M Yaniv
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

10.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.